Palatin Technologies logo
Palatin Technologies PTN
$ 21.79 1.33%

Quarterly report 2025-Q4
added 02-17-2026

report update icon

Palatin Technologies Operating Cycle 2011-2026 | PTN

Annual Operating Cycle Palatin Technologies

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 119 818 418 -94.9 - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
818 -94.9 315

Quarterly Operating Cycle Palatin Technologies

2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
3.49 K - - - - - - - 82.9 92.4 - 134 170 951 61.8 2.34 K 3.63 K 2.63 K 1.58 K 9.17 K 15.6 K 9.69 K - -18.7 477 28.3 K 267 K 28.2 K - 136 - - 40.4 K 41.5 K 130 25.6 - - - - - - - - 17.3 K - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
267 K -18.7 18.9 K

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
Acorda Therapeutics Acorda Therapeutics
ACOR
394 - -24.86 % $ 820 K usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
102 $ 330.55 -0.85 % $ 43.3 B usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
32 - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
245 - -18.52 % $ 27.3 M britainBritain
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
237 $ 21.68 - $ 1.01 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
115 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
210 $ 1.5 -3.23 % $ 386 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
223 $ 4.24 -0.12 % $ 453 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
291 $ 24.54 -0.18 % $ 3.12 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
436 - -4.8 % $ 255 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
129 $ 1.48 -1.01 % $ 394 M britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Caladrius Biosciences Caladrius Biosciences
CLBS
164 - -16.75 % $ 25.8 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
61.7 - - $ 25.3 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
321 $ 33.97 0.3 % $ 2.26 B usaUSA
bluebird bio bluebird bio
BLUE
127 - - $ 546 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
206 - - $ 96.9 B britainBritain